Is Schizophrenia Genetic?

Both conditions are more common than many people assume. Mental Health America estimates a 5.9% lifetime prevalence for borderline personality disorder (BPD) and notes that patients with a BPD diagnosis may represent about 20% of the psychiatric inpatient population. The World Health Organization reports that in 2021, approximately 37 million people worldwide (0.5%) were living with bipolar disorder. These are not rare diagnoses and in real-world clinical settings, both appear frequently, sometimes in overlapping presentations.

That overlap is where confusion begins. The symptoms can look similar on the surface: mood instability, impulsivity, depression, irritability, and relationship strain. Many people find themselves questioning their diagnosis, reading conflicting information online, or starting treatment that doesn’t fully address what’s actually happening.

In this guide, we’ll break down each condition clearly, focusing on differences in timing, episode structure, triggers, and long-term patterns. We will explain how clinicians distinguish bipolar disorder and borderline personality disorder, so you can move toward a more accurate understanding and seek the appropriate care.

What Is Borderline Personality Disorder?

Borderline personality disorder (BPD) is a mental health condition marked by long-standing erratic patterns in emotion regulation, relationships, self-image, and impulse control. It isn’t a character flaw. Many people can function well day to day, yet experience intense inner distress, especially in close relationships. Symptoms tend to persist over time and may affect judgment, communication, and stability when stress rises, and self-doubt often occurs.

Common features include:

• Fear of abandonment or separation sensitivity
• Intense, fast-shifting emotions
• Unstable relationship patterns
• Shifting self-image or goals
• Impulsive reactions under distress
• Chronic emptiness
• Anger that is hard to calm

Key Symptoms and Patterns in BPD

In BPD, shifts in mood are often reactive to interpersonal stress (conflict, distance, or perceived rejection) and can change within minutes to hours. The signal is the pattern over time and the impact on functioning, not a single “bad day.” People may notice that reassurance helps briefly, emotions don’t return to baseline quickly or easily, and impulses rise under distress.

• Emotions: Intense spikes, slow recovery
• Relationships: Closeness–doubt swings
• Sense of self: Unstable identity
• Behaviors: Urgent contact, impulsive choices

What Is Bipolar Disorder?

Bipolar disorder is a mood disorder defined by distinct episodes of depression and mania or hypomania that last days to weeks, sometimes longer. These are not ordinary mood swings. Episodes involve clear shifts in energy, sleep, activity level, and judgment that affect daily functioning. Between episodes, many people return to a more stable baseline.

Understanding how bipolar disorder unfolds over time is essential when comparing BPD vs bipolar disorder, because the timing and structure of mood changes are different.

Common episode features include:

• Elevated or irritable mood during mania/hypomania
• Decreased need for sleep without fatigue
• Increased goal-directed activity or impulsive decisions
• Depressive episodes with low energy and loss of interest
• Impaired judgment during elevated states

Key Symptoms and Patterns in Bipolar Disorder

Bipolar disorder shows up as clearly defined episodes, not moment-to-moment shifts. Mood states persist and noticeably affect functioning at work, school, or in relationships. The intensity and duration are central to diagnosis:

• Mania: Markedly elevated or irritable mood, reduced sleep, risky decisions, significant functional impact
• Hypomania: Similar but less severe, still noticeable change in behavior
• Depression: Sustained low mood, fatigue, slowed thinking, reduced functioning

Borderline Personality Disorder vs Bipolar Disorder: The Key Differences

Episode Duration and Timing

A core difference is how long mood and behavior changes typically last. In bipolar disorder, manic, hypomanic, and depressive episodes usually persist for days to weeks, sometimes longer, and create a sustained shift from a person’s baseline. In BPD, emotional changes can be faster and more reactive, often rising and settling within minutes to hours. Timing alone doesn’t confirm a diagnosis, but it is a useful clinical clue when assessing patterns over time.

Triggers: Reactive vs Episodic

Another distinction is what tends to set symptoms in motion. BPD shifts are often linked to interpersonal stress, like conflict, distance, misunderstanding, or perceived rejection, and the emotional response may feel immediate and intense. Bipolar episodes can emerge without a clear external trigger, even though stress, sleep disruption, and substances may contribute. The goal is not to “blame” triggers, but to understand what reliably precedes symptom changes, which helps guide assessment and treatment planning.

Identity and Relationships

BPD commonly involves an unstable sense of self and intense relationship patterns that can swing between closeness and distrust. People may feel uncertain about who they are, what they want, or how they should be with others, especially under stress. Bipolar disorder can also strain relationships, but often primarily during mood episodes when energy, judgment, and behavior change significantly. This contrast between bipolar disorder and borderline personality disorder is one reason clinicians focus on long-term patterns, not isolated moments.

Symptoms That Overlap

Some symptoms can appear in both conditions, which is why a professional assessment matters. Mood changes, irritability, impulsivity, and symptoms of depression or anxiety can look similar on the surface, especially when someone is under stress. Clinicians focus on the full history, episode patterns, and functional impact over time to clarify what is driving the symptoms. Research has noted that symptomatic overlap between bipolar disorder and borderline personality disorder can contribute to diagnostic confusion when patterns are not carefully assessed.

Overlaps:

• Mood instability
• Irritability
• Impulsive decisions
• Depressive symptoms
• Anxiety symptoms

Diagnostic indicators:

• Sustained episodes with clear baseline shifts
• Rapid reactivity linked to interpersonal stress
• Consistent patterns in self-image and relationships

Can You Have Bipolar Disorder and Borderline Personality Disorder?

Co-occurrence can happen, and it can make the clinical picture more complex - especially when mood episodes and interpersonal reactivity overlap. In these cases, treatment is most effective when it is individualized and based on careful tracking of symptoms over time. The goal is to identify which symptoms reflect episodic mood shifts, which reflect longer-term regulation patterns, and what supports stability in daily life. With a clear formulation, there is a plan: targeted therapy, monitoring, and coordinated care.

How Diagnosis Works: Borderline Personality Disorder vs Bipolar Disorder

Diagnosis is based on a careful clinical history over time, not a single quiz or symptom checklist. Clinicians look at the pattern, duration, and severity of mood changes, what tends to trigger them, and how symptoms affect sleep, judgment, work, and relationships. Providers often track episodes across weeks or months and may use structured interviews to clarify patterns. They also rule out medical conditions, substance use, trauma-related symptoms, and medication effects that can mimic mood instability before confirming a diagnosis.

Treatment Differences: What Actually Helps

Treatment is most effective when it aligns with the underlying condition. In bipolar disorder and borderline personality disorder, the focus of care differs because the mechanisms driving symptoms are different:

• For bipolar disorder, treatment prioritizes mood stabilization and prevention of future episodes. This typically includes medication management, psychotherapy, and structured daily routines that protect sleep and reduce relapse risk. The goal is to minimize episode frequency and intensity while preserving long-term functioning.
• For BPD, treatment usually centers on structured psychotherapy that builds emotional regulation, distress tolerance, and interpersonal effectiveness. Dialectical Behavior Therapy (DBT) is one of the most established approaches. The goal is greater emotional stability, safer coping strategies, and more consistent relationship patterns over time.

Getting Care at Amae Health

At Amae Health, care begins with a structured, evidence-based assessment designed to clarify diagnosis and guide treatment planning. Our team evaluates symptom history, episode patterns, functional impact, and co-occurring conditions before making recommendations. We provide clear diagnostic feedback, individualized treatment plans, and ongoing monitoring to track progress and adjust care when needed.

Depending on your needs, treatment may include our Intensive Outpatient Program (IOP) or Partial Hospitalization Program (PHP), along with psychiatric support and skills-based therapy.

If you’re ready for clarity, stability, and evidence-based treatment, schedule a confidential evaluation or consultation today.

‍

You heard your name called in an empty apartment. You saw a shadow move at the edge of your vision during a week of almost no sleep. Now you're wondering whether stress can actually make you hallucinate, or whether something more serious is going on.

Stress can contribute to hallucination-like experiences, especially when it comes with severe sleep loss, grief, or trauma. Brief, isolated experiences like these are more common than most people realize. But hallucinations that keep coming back, that come with unusual beliefs, or that change how someone functions need a prompt evaluation, because they can be an early sign of psychosis, and early treatment matters.

How common are hallucinations?

More common than you might think. A 2015 study in JAMA Psychiatry surveyed 31,261 adults across 18 countries and found that 5.2% had experienced a hallucination at some point in their lives. Most of these experiences were rare: about a third of people with any psychotic experience reported it happening only once.

A single odd experience doesn't mean you have a psychotic disorder. Many people have one and never have another.

Can stress cause hallucinations?

The research points to stress acting mostly through other pathways:

Sleep deprivation

This is the clearest link. Stress disrupts sleep, and severe sleep loss reliably distorts perception. A 2018 systematic review of 21 studies with 760 healthy participants found that perceptual distortions, anxiety, and irritability began within 24 to 48 hours without sleep, and complex hallucinations appeared after 48 to 90 hours. Visual changes were the most common. In many cases, a period of normal sleep resolved the symptoms.

Grief

MedlinePlus notes that briefly hearing the voice of, or seeing, a loved one who recently died can be a normal part of grieving. These experiences are common and usually not a sign of mental illness.

Stress in people who already hear voices

For people who already experience hallucinations, stress can make them worse. A 2024 study in Schizophrenia Research from Yale's Control Over Perceptual Experiences (COPE) Project surveyed 278 people with a history of hearing voices and found that recent social stress was associated with both how often they heard voices and how distressing the voices were.

Severe stress and brief psychosis

Occasionally, an episode of psychosis appears suddenly and resolves within a month. Brief psychotic disorder, as described in the DSM-5, involves the sudden onset of symptoms such as hallucinations, delusions, or disorganized speech lasting from one day to one month, with a full return to normal functioning afterward. It still needs medical care while it's happening.

Can anxiety cause hallucinations?

Research on anxiety and true hallucinations is limited. What clinicians commonly hear from people with severe anxiety or panic is that perception feels strange: they feel detached from their surroundings, unreal, or hyper-alert to sounds and movement. Combined with exhaustion and poor sleep, that state can lead to misperceptions, such as hearing a phone ring or a voice in background noise.

These experiences usually pass when the anxiety eases, and the person recognizes afterward that they weren't real. If hallucinations happen when you're calm and rested, or you're not sure they weren't real, that's a different situation.

Other causes of hallucinations

Stress is only one possibility. According to MedlinePlus, causes of hallucinations include:

• Being drunk or high, or coming down from drugs, including alcohol, marijuana, stimulants, and hallucinogens
• Delirium or dementia
• Epilepsy, especially of the temporal lobe
• High fever, particularly in children and older adults
• Narcolepsy
• Severe illness such as liver or kidney failure
• Sensory loss, such as blindness or deafness
• Mental illnesses such as schizophrenia and psychotic depression

The NIMH adds sleep deprivation, certain prescription medications, and alcohol or drug misuse to the list of possible causes of psychosis. That's why a medical evaluation usually comes first.

Stress hallucinations vs. psychosis: how to tell the difference

No checklist can sort this out on its own, but these patterns point toward a stress-related or situational experience:

• It happened once or a few times, during clear extremes such as sleep loss or grief
• You knew, at the time or soon after, that it wasn't real
• It stopped when you slept, rested, or the stress eased
• Nothing else about your thinking or behavior changed

These point toward something that needs prompt evaluation:

• Hallucinations that keep happening, especially hearing voices
• Beliefs that others find strange, such as feeling watched, targeted, or sent special messages
• Withdrawing from people, a drop in work or school performance, or neglecting self-care
• Trouble telling what's real

The NIMH lists warning signs that often appear before a first episode of psychosis, including suspiciousness, trouble thinking clearly, social withdrawal, a decline in self-care, disrupted sleep, and difficulty telling reality from fantasy. Psychosis most often begins between the late teens and mid-20s.

When to get help

MedlinePlus advises that a person who begins to hallucinate and is detached from reality should be checked by a health care provider right away, because many causes can quickly become emergencies. If someone is confused, at risk of harming themselves or others, or can't be left alone safely, call 911 or go to the emergency room. If there are thoughts of suicide, call or text 988.

For hallucinations that come and go without an emergency, start with a primary care visit to look for medical causes, then a psychiatric evaluation if needed.

Don't wait it out if the signs point toward psychosis. The NIMH notes that people often have psychotic symptoms for more than a year before getting treatment, and that shortening this untreated period matters because early treatment often means better recovery.

How stress-related hallucinations are managed

When stress and sleep loss are the drivers, treatment usually targets them directly: restoring sleep, reducing stressors, and treating any underlying anxiety or depression. Grief-related experiences often fade on their own with time and support.

When hallucinations are part of psychosis, treatment is more specialized. According to the NIMH, treatment of psychosis usually includes antipsychotic medication. Coordinated specialty care, a multi-element team approach that involves the person and their family in shared decision-making, is now the standard of care for early psychosis, and outcomes are better when it starts soon after symptoms appear.

At Amae Health, our clinics specialize in conditions including first-episode psychosis, schizophrenia, and schizoaffective disorder (see our overview of schizophrenia treatment options). Our care teams bring psychiatrists, therapists, primary care physicians, peer mentors, and care coordinators under one roof, working from one treatment plan. Learn how we treat psychosis, or read about the difference between psychosis and schizophrenia.

Frequently asked questions

Can stress make you hallucinate?

It can contribute, mostly through severe sleep loss, grief, or in people who already experience hallucinations. Isolated experiences during extreme stress are fairly common. Repeated hallucinations need an evaluation.

Can anxiety cause auditory hallucinations?

Anxiety can heighten alertness so that ordinary sounds are misheard, especially when you're exhausted. True, recurring voices are not a typical symptom of anxiety and should be evaluated.

Are stress hallucinations dangerous?

A single experience during extreme sleep loss or grief usually isn't. But hallucinations with confusion, detachment from reality, or thoughts of harm need urgent care, and recurring hallucinations can be an early sign of psychosis.

Do stress hallucinations go away?

Those caused by sleep loss often resolve after normal sleep, according to research on sleep deprivation. If hallucinations continue after you've rested and the stress has eased, see a clinician.

Key takeaways

• Stress can contribute to hallucinations, mostly through severe sleep loss, grief, or by worsening existing symptoms.
• About 5% of adults report a hallucination at some point, usually once or rarely.
• Recurring hallucinations, unusual beliefs, withdrawal, or trouble telling what's real need prompt evaluation.
• Early treatment of psychosis leads to better recovery, so don't wait it out.

If you or someone you love is experiencing hallucinations that keep coming back, request an intake appointment. Our team will explain how an evaluation works and what to expect from the first visit.

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍